Koers BioScrip Inc Nasdaq
Aandelen
US09069N1081
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 4,75 mld. 4,43 mld. | Omzet 2025 * | 5,18 mld. 4,82 mld. | Marktkapitalisatie | 4,75 mld. 4,43 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 203 mln. 189 mln. | Nettowinst (verlies) 2025 * | 234 mln. 218 mln. | EV/omzet 2024 * | 1,13 x |
Nettoschuld 2024 * | 598 mln. 557 mln. | Nettoschuld 2025 * | 400 mln. 373 mln. | EV/omzet 2025 * | 1 x |
K/w-verhouding 2024 * |
23,5
x | K/w-verhouding 2025 * |
20,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,86% |
Recentste transcriptie over BioScrip Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 06-08-19 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 01-01-15 |
Caroline Budde
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 07-08-19 |
David Golding
BRD | Director/Board Member | 62 | 01-05-15 |
John Arlotta
BRD | Director/Board Member | 74 | 07-08-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,75% | 82,53 mld. | |
-26,58% | 73 mld. | |
-1,13% | 26,4 mld. | |
-10,66% | 17,12 mld. | |
+1,21% | 17,09 mld. | |
-0,50% | 15,23 mld. | |
+77,01% | 13,24 mld. | |
+76,01% | 13,02 mld. | |
-25,09% | 12,82 mld. |